Ariel Pharmaceuticals

Ariel Pharmaceuticals, Inc. is a private specialty pharmaceutical company focused on development and commercialization of products for

Ariel Pharmaceuticals, Inc. is a private specialty pharmaceutical company focused on development and commercialization of products for acute CNS and trauma. Ariel's business model is based on significant reduction of shareholder risk and short time to value inflection. They achieve this by in-licensing drugs that are already in human testing for clinical indications that have short development timelines, well-defined endpoints for efficacy, and established mechanism-of-action to ensure predictability and cost efficiency.